PDX INSIGHTS
PIONEERING CANCER RESEARCH
Model Details

Patient Information for Model: TCH-HB03

Model Contact
Model: TCH-HB03
Model Contact: Sarah Woodfield
Institution: TCH Liver PDX Program
Email: sewoodfi@texaschildrens.org

Patient Information
Clinical Timeline

Color Keys:
 
 Unknown
 None
 Low
 Moderate
 High
 Very High

Clinical Information at Collection
Pathology Information at Collection

Model Information for Model: TCH-HB03

Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Mutations (Cancer Gene Census List)
Mutation data is currently not available.

CNV
There are no omics data for this model.


Histology Information for Model: TCH-HB03
There are no histology images for this model.













Metastasis Information for Model: TCH-HB03
 
Patient
PDX
Lung

Patient Treatment Information for Model: TCH-HB03

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationPathologic ResponseReason Stopped
15Chemotherapy NOSNeoadjuvant1.92.037 days
25Vincristine 2nd CycleAdjuvant2.062.074 daysComplete ResponseAFP 5.2
35Vincristine 3rd CycleAdjuvant2.162.174 days
55Off Therapy Follow-upAdjuvant2.422.434 daysComplete ResponseAFP 4.1













Please wait...